NCT07247812 tSCS in Children and Young People With HCP
| NCT ID | NCT07247812 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Leeds |
| Condition | Cerebral Palsy Spastic Hemiplegic |
| Study Type | INTERVENTIONAL |
| Enrollment | 18 participants |
| Start Date | 2026-04-29 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 18 participants in total. It began in 2026-04-29 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This work will examine if a technique called Transcutaneous Spinal cord stimulation (tSCS), when used with concurrent specific arm and hand exercises, helps improve arm and hand movements in CYP with HCP. Does Transcutaneous Spinal Cord Stimulation (tSCS), when combined with specific arm and hand exercises, improve upper limb function in children and young people (CYP) with Hemiplegic Cerebral Palsy (HCP)? -To determine the feasibility and effectiveness of Transcutaneous Spinal Cord Stimulation (tSCS) combined with targeted arm and hand exercises in improving the upper limb function in children and young people with Hemiplegic Cerebral Palsy (HCP).
Eligibility Criteria
Inclusion Criteria * Age and Gender: Boys and girls aged 12 to 21 years. * Diagnosis: Are diagnosed with Hemiplegic Cerebral Palsy (HCP). * Hand Function: Are experiencing difficulties with hand functions in daily activities. * Medical Stability: Have stable medical conditions without cardiopulmonary disease or seizures. * Motor Capability: Are capable of performing simple motor tasks such as reaching, touching, or grasping objects. * Availability: Are able to attend two sessions * Consent informed: Are able to provide informed consent (or if under 16, will need to have a parent or legal guardian who is willing to provide consent on their behalf). * Language: Are able to speak English (and if under 16, their parent or legal guardian must also be able to speak English) Exclusion Criteria * Other Neurological Conditions: Have neurological diseases other than cerebral palsy. * Blood Pressure: Have uncontrolled or high blood pressure. * Recent Surgeries: Have recently undergone significant surgeries (neurological, cardiac, respiratory, or metabolic) without sufficient recovery time. * Severe Diseases: Have cardiovascular or pulmonary diseases. * Medical Complications: Have ongoing medical complications such as unhealed fractures, contractures, or active infections or cancer. * Protocol Compliance: Are unable to follow study protocols safely. * Epilepsy History: Have a personal or family history of epilepsy. * Recent Injections: Have had botulinum toxin injections within the past six months. * Implanted Devices: Have implanted devices like pacemakers or baclofen pumps. * Exclusion of Participants with Recent Research Involvement: Participants who have taken part in any clinical research study within the last 3 months will be excluded.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07247812 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 21 Years, studying Cerebral Palsy Spastic Hemiplegic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07247812 currently recruiting?
Yes, NCT07247812 is actively recruiting participants. Contact the research team at Bsothn@leeds.ac.uk for enrollment information.
Where is the NCT07247812 trial being conducted?
This trial is being conducted at Leeds, United Kingdom.
Who is sponsoring the NCT07247812 clinical trial?
NCT07247812 is sponsored by University of Leeds. The trial plans to enroll 18 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.